NewStem
Biopharmaceutical company developing human haploid stem cells for regenerative medicine and disease therapy.
About
NewStem is a biopharmaceutical company specializing in Human Pluripotent Stem Cells (HPSCs), with a particular focus on Human Haploid Pluripotent Stem Cells (HHPSCs). These unique cells hold significant potential for advancing regenerative medicine and developing novel therapies for various diseases.
Technology stack
detected 2026-06-16Est. monthly stack spend~$70/mo
Emailnone
Comments
No comments yet. Be the first to share your take.
Frequently asked
What does NewStem do?
NewStem is a biopharmaceutical company specializing in Human Pluripotent Stem Cells (HPSCs), with a particular focus on Human Haploid Pluripotent Stem Cells (HHPSCs). These unique cells hold significant potential for advancing regenerative medicine and developing novel therapies for various diseases.
How much funding has NewStem raised?
NewStem has raised a total of $30M in funding. The most recent round on record is Series B.
Where is NewStem headquartered?
NewStem is headquartered in Rehovot, Israel.
When was NewStem founded?
NewStem was founded in 2018.
What industry does NewStem operate in?
NewStem operates in Life Sciences, Biotech, Biopharmaceutical, MedTech, HealthTech, Drug Discovery.